Navigation Links
RainDance Technologies Appoints McNary President and CEO
Date:11/28/2007

GUILFORD, Conn., Nov. 28 /PRNewswire/ -- RainDance Technologies, Inc., a developer of NanoReactor droplet-based microfluidic technology, today announced the appointment of Christopher McNary as President and Chief Executive Officer. McNary will join Jonathan Rothberg, Chairman of the Board, in driving RainDance Technologies' vision and the upcoming commercial launch of its Professional Laboratory System in the Life Sciences and other related markets.

"Mr. McNary joins an outstanding leadership team that includes a distinguished Scientific Advisory Board with three Nobel Prize recipients and a Board of Directors with the former Presidents of Applied Biosystems and Affymetrix, plus an experienced Partner from Mohr Davidow Ventures," said Rothberg. "He will assist us in attracting additional talent to develop first-rate manufacturing and customer support capabilities and to commercially launch our exciting new products and applications."

The RainDance Professional Laboratory System combines microdroplets and microfluidics to enable a host of nanoscale cell-based and molecular assays. Samples (cells, beads, DNA templates, chemical compounds) and reactants are encapsulated in individual micron-sized droplets on assay-specific NanoReactor chips. With each droplet being the equivalent of a well in a microtiter plate, the Professional Laboratory System can process and analyze 10,000 samples per second with unparalleled accuracy. The precise manipulation of minute amounts of fluids within NanoReactor droplets will benefit a variety of industrial and research applications, including DNA sequencing preparation, enzyme engineering, functional cell sorting, multiplex PCR, SNP detection, gene expression, and RNAi functional assays.

"Our Professional Laboratory System is game-changing technology that has attracted a tremendous level of market interest," said Darren Link, Senior Vice President of Research and Development and RainDance Technologies founde
'/>"/>

SOURCE RainDance Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/...l to market Oralair(R) in both adults and children...the first country where,Oralair(R) has been market...lair(R) is now registered in Austria, Belgium, Bul..., Germany, Greece, Hungary, Ireland, Italy,Latvia...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech...virus, genomic data from the 1918 pandemic through...rent H1N1 pandemic, today issued its latest bioche...at the lethality of the H1N1 ("Swine Flu") virus h...the virus,s current outbreak in the spring of 2009...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/...er and provider of vaccines, announced today that ...blish Sinovac (Dalian) Vaccine,Technology Co., Ltd... produce,and commercialize human-use vaccines. Sin...in developing and commercializing world-class vacc...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ -...r of electrical and communications systems and ser...al markets, announced today that its commercial bu...attan Torcon JV to install the electrical systems ... facility at the U.S. Army Medical Research Instit...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
... and WHITEHOUSE STATION, N.J., April 25 ,Schering-... that it,received a not-approvable letter from the...posed fixed combination of loratadine and monteluk...s in patients who want relief,from nasal congestio...e/montelukast was accepted,by the FDA for standard...
...FRANCISCO, Calif., April 25 ,Renovis, Inc. (Nasdaq...Inc.,and Egan-Jones Proxy Services have joined ISS...g that Renovis stockholders vote "FOR" the merger,...: EVT) at the Special,Meeting of Stockholders sche... share of Renovis common stock will be converted i...
...NTY, Calif., April 25 Beckman,Coulter, Inc. (NYSE...rs,declared a quarterly dividend payout of sevente...tock, payable on May 23, 2008 to all stockholders ...he 76th consecutive,quarterly payout of dividends....31202/BECLOGO ), Beckman Coulter, Inc., based in ...
Other Biology Technology:Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast 2Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast 3Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec 2Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec 3
(Date:11/26/2009)...(November 26, 2009) Whitehead researchers have de...ls to pinpoint specific genes and proteins used by... , In most human cell cultures genes are present...one from the mother. Gene inactivation by mutation... inactivated, the second copy usually remains acti...
(Date:11/25/2009)...eria don,t have easy lives. In addition to mammali... natural enemies called bacteriophages, viruses th... , Still, bacteria and another class of microor...e environments such as deep-sea volcanic vents) ma...ve a built-in defense system that helps protect th...
(Date:11/25/2009)...iversity assistant professors recently received fu...o continue research beneficial to understanding th... Christopher Blackwood, assistant professor in th...rants to support two separate research projects. ,...composer Communities and Functions from the Leaf t...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 13733 1Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 13733 2Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 13733 3Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference 13733 4Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 1Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 2Researchers identify protein involved in causing gum disease osteoporosis arthritis 55657 3Young Athletes at Risk of Heat Injury 55656 1Young Athletes at Risk of Heat Injury 55656 2
... basic components of living things, are among the ...ing how proteins form or "fold" from sequenced str... challenges of biology. , A common belief holds t...nment, the more stable - or less likely to unfold ...e March issue of Biophysical Journal, a team of ch...
...velop their preference for speech through in-utero...nate? It,s a bedevilling question to test, but one...ynamics of humans unique propensity for speech. No...separated out the complicating effects of the uter...a Vouloumanos, point to a genetic predilection for...
...sts and engineers at the University of Toronto des...ould help satisfy society,s never-ending hunger fo...d even lead to new methods for delivering medicati...iodic mesoporous organosilica (PMO), is a thin fil... metre across. The team created it by mixing an or...
Other Biology News:UW-Madison engineers squeeze secrets from proteins 2Born with a love of speech 2Born with a love of speech 3
Corning Culture Flask, 25 cm2, Tc-Treated, Canted Neck, Plug Seal, Sterile from Sigma-Aldrich
...y clear polystyrene with frosted labeling surfaces...for cell counting. 100% integrity tested. Linkage:...to easily match Cornings product number. If showin...Sigma-Aldrich number (C0427) or contact customer s...
LIC Duet™ T7•Tag® Ek Adaptor from Novagen
LIC Duet™ Minimal Adaptor from Novagen
Biology Products: